IMPUF vs. CAPR
IMPUF (Impala Platinum Holdings Ltd) and CAPR (Capricor Therapeutics, Inc.) are both stocks. IMPUF operates in Other Precious Metals & Mining (Basic Materials), while CAPR operates in Biotechnology (Healthcare). Over the past 5 years, IMPUF returned -2.36%/yr vs 39.47%/yr for CAPR. At a 0.03 correlation, their price movements are largely independent.
Performance
IMPUF vs. CAPR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IMPUF achieves a -24.09% return, which is significantly lower than CAPR's 2.56% return.
IMPUF
- 1D
- 0.00%
- 1M
- -14.46%
- YTD
- -24.09%
- 6M
- -27.82%
- 1Y
- 46.96%
- 3Y*
- 12.87%
- 5Y*
- -2.36%
- 10Y*
- —
CAPR
- 1D
- 0.89%
- 1M
- 2.53%
- YTD
- 2.56%
- 6M
- 2.42%
- 1Y
- 285.42%
- 3Y*
- 80.30%
- 5Y*
- 39.47%
- 10Y*
- -3.39%
IMPUF vs. CAPR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
IMPUF Impala Platinum Holdings Ltd | -24.09% | 200.45% | 12.15% | -60.02% | -5.41% | 12.03% | 50.30% | 410.99% |
CAPR Capricor Therapeutics, Inc. | 2.56% | 109.13% | 182.21% | 26.68% | 31.74% | -14.58% | 167.97% | -69.39% |
Correlation
The correlation between IMPUF and CAPR is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.04 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.04 |
Correlation (All Time) Calculated using the full available price history since Feb 25, 2019 | 0.03 |
Fundamentals
IMPUF:
$10.40B
CAPR:
$1.70B
IMPUF:
-ZAR 9.66
CAPR:
-$2.32
IMPUF:
1.77
CAPR:
0.01
IMPUF:
ZAR 188.26B
CAPR:
$0.00
IMPUF:
ZAR 17.78B
CAPR:
-$42.41M
IMPUF:
ZAR 29.69B
CAPR:
-$117.24M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IMPUF vs. CAPR — Risk / Return Rank
IMPUF
CAPR
IMPUF vs. CAPR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Impala Platinum Holdings Ltd (IMPUF) and Capricor Therapeutics, Inc. (CAPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IMPUF | CAPR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.14 | ||
| Sortino ratioReturn per unit of downside risk | -4.84 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.80 | -0.56 |
| Calmar ratioReturn relative to maximum drawdown | 0.94 | 4.81 | -3.87 |
| Martin ratioReturn relative to average drawdown | 2.04 | 9.95 | -7.91 |
Loading charts...
Drawdowns
IMPUF vs. CAPR - Drawdown Comparison
The maximum IMPUF drawdown since its inception was -80.80%, smaller than the maximum CAPR drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for IMPUF and CAPR.
Loading charts...
Drawdown Indicators
| IMPUF | CAPR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.80% | -99.97% | +19.17% |
Max Drawdown (1Y)Largest decline over 1 year | -50.24% | -59.72% | +9.48% |
Max Drawdown (3Y)Largest decline over 3 years | -59.31% | -79.08% | +19.77% |
Max Drawdown (5Y)Largest decline over 5 years | -79.84% | -79.08% | -0.76% |
Max Drawdown (10Y)Largest decline over 10 years | — | -97.83% | — |
Current DrawdownCurrent decline from peak | -47.98% | -99.09% | +51.11% |
Average DrawdownAverage peak-to-trough decline | -41.80% | -90.25% | +48.45% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 23.08% | 28.83% | -5.75% |
Volatility
IMPUF vs. CAPR - Volatility Comparison
Impala Platinum Holdings Ltd (IMPUF) has a higher volatility of 16.05% compared to Capricor Therapeutics, Inc. (CAPR) at 14.02%. This indicates that IMPUF's price experiences larger fluctuations and is considered to be riskier than CAPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IMPUF | CAPR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.05% | 14.02% | +2.03% |
Volatility (6M)Calculated over the trailing 6-month period | 59.82% | 49.35% | +10.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 76.72% | 382.74% | -306.02% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 64.24% | 189.98% | -125.74% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 107.01% | 179.73% | -72.72% |
Dividends
IMPUF vs. CAPR - Dividend Comparison
IMPUF's dividend yield for the trailing twelve months is around 2.08%, while CAPR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
CAPR Capricor Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IMPUF Impala Platinum Holdings Ltd | 2.08% | 0.00% | 0.00% | 6.80% | 7.85% | 10.80% | 1.75% |
Financials
IMPUF vs. CAPR - Financials Comparison
This section allows you to compare key financial metrics between Impala Platinum Holdings Ltd and Capricor Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IMPUF and CAPR have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IMPUF has higher volatility (16.05%) compared to CAPR (14.02%). In terms of maximum drawdown, IMPUF dropped -80.80% vs CAPR's -99.97%.
CAPR currently has the higher Sharpe Ratio (0.75 vs 0.62), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IMPUF and CAPR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer